@ARTICLE{
author={Tarabar Olivera K,Cikota-Aleksic Bojana M,Tukic Ljiljana J,Milanovic Nenad,Aleksic Aleksandar,Magic Zvonko M},
year={2014},
title={Association of interleukin-10, tumor necrosis factor-alpha and transforming growth factor-beta gene polymorphisms with the outcome of diffuse large B-cell lymphomas},
journal={INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY},
volume={19},
number={1},
pages={186-192},
document_type={Article},
} 

@ARTICLE{
author={Matic Ivana Z,Djordjevic Milica Z,Djordjic Marija J,Grozdanic Nadja Dj,Damjanovic Ana B,Kolundzija Branka S,Vidovic Ana D,Bila Jelena S,Ristic Slobodan,Mihaljevic Biljana S,Tomin Dragica S,Milanovic Nenad,Ristic Dusan J,Puric Mila,Gavrilovic Dusica,Cordero Oscar J,Juranic Zorica D},
year={2013},
title={Dipeptidyl peptidase IV: serum activity and expression on lymphocytes in different hematological malignancies},
journal={LEUKEMIA & LYMPHOMA},
volume={54},
number={12},
pages={2701-2706},
document_type={Article},
} 

@ARTICLE{
author={Milanovic Nenad,Matkovic Suzana V,Ristic Dusan J,Jelic Svetislav B,Petrovic Milan D},
year={2012},
title={Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma},
journal={JOURNAL OF BUON},
volume={17},
number={3},
pages={497-501},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Babovic Nada Lj,Kovcin Vladimir N,Milicevic N,Milanovic Nenad,Popov Ivan P,Radosavljevic Davorin Z},
year={2002},
title={Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study},
journal={MELANOMA RESEARCH},
volume={12},
number={1},
pages={91-98},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Babovic Nada Lj,Kreacic Miroslav,Matkovic Suzana V,Milanovic Nenad,Gavrilovic Dusica,Tomasevic Zoran M},
year={1999},
title={Epirubicin 150 mg/m(2)-cisplatin versus epirubicin 180 mg/m(2)-cisplatin for advanced soft tissue sarcoma},
journal={INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH},
volume={19},
number={4},
pages={129-138},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Milanovic Nenad,Tomasevic Zorica I,Matkovic Suzana V,Gavrilovic Dusica},
year={1999},
title={Comparison of two non-anthracycline-containing regimens for elderly patients with diffuse large-cell non Hodgkin's lymphoma - possible pitfalls in results reporting and interpretation},
journal={NEOPLASMA},
volume={46},
number={6},
pages={394-399},
document_type={Article},
} 

